Journal
BIOCHEMICAL PHARMACOLOGY
Volume 167, Issue -, Pages 13-26Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2019.06.001
Keywords
ADP-ribosylation; ADP-ribosyl transferase (ART); ART bacterial toxins; Antimicrobial strategies; Poly(ADP-ribose) polymerase (PARP)
Categories
Funding
- Italian Foundation for Cancer Research [FIRC, Milan, Italy] [14895]
- PRONAT project
- SATIN POR project 2014-2020
- Italian MIUR Cluster project Medintech [CNT01_00177_962865]
- Italian Association for Cancer Research [TRIDEO, AIRC-Fondazione Cariplo, Milan, Italy] [IG17524]
Ask authors/readers for more resources
ADP-ribosylation (ADPr) is an ancient reversible modification of cellular macromolecules controlling major biological processes as diverse as DNA damage repair, transcriptional regulation, intracellular transport, immune and stress responses, cell survival and proliferation. Furthermore, enzymatic reactions of ADPr are central in the pathogenesis of many human diseases, including infectious conditions. By providing a review of ADPr signalling in bacterial systems, we highlight the relevance of this chemical modification in the pathogenesis of human diseases depending on host-pathogen interactions. The post-antibiotic era has raised the need to find alternative approaches to antibiotic administration, as major pathogens becoming resistant to antibiotics. An in-depth understanding of ADPr reactions provides the rationale for designing novel antimicrobial strategies for treatment of infectious diseases. In addition, the understanding of mechanisms of ADPr by bacterial virulence factors offers important hints to improve our knowledge on cellular processes regulated by eukaryotic homologous enzymes, which are often involved in the pathogenesis of human diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available